Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02903368
Title Neoadjuvant And Adjuvant Abiraterone Acetate + Aptilutamide Prostate Cancer Undergoing Prostatectomy
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Leuprolide + Prednisone

Abiraterone + Apalutamide + Leuprolide + Prednisone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.